Logo Prestige Consumer Healthcare

Prestige Consumer Healthcare (PBH) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Prestige Consumer Healthcare · Health Care · ref. ETF XLV · 54 calls · price $51.21
🏆JPI 2026 portfoliosSee tracking →
What the company does: Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

📈 Prestige Consumer Healthcare (PBH) stock price

$51.21-23.9% over range
Aug 28, 25low $45.44 · high $70.21Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
50% recommend buying · 2 analysts
📊 JPI status : Prestige Consumer Healthcare has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 PBH price target & analyst consensusprice $51.21

The price target · all analysts combined (1 targets)
Highest target · 1 firm of 1$72+40.6%
Median target · of 1 targets$72+40.6%
Lowest target · 1 firm of 1$72+40.6%
Current price$51.21
⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

The consensus · 2 ratings (last 6 months)
Strong Buy00%
Buy150%
Hold150%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Prestige Consumer Healthcare? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

✅ Historical analyst reliability on PBH

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
Jefferies  75% +5.6% 4
Oppenheimer  62% +26.8% 8
Sidoti & Co. 50% +30.4% 2
Raymond James  50% +8.4% 2
Keybanc  50% -4.7% 2
DA Davidson  29% -6.0% 7
Canaccord Genuity  20% -2.6% 5

📊 What $1,000 invested in Prestige Consumer Healthcare would be worth › open the full page

In short — $1,000 invested in Prestige Consumer Healthcare 10 years ago would be worth $917 today, i.e. -1%/yr on average. Best year: 2021 (+74%), worst: 2018 (-30%). Price performance, excluding dividends.

If I'd invested $1,000 in Prestige Consumer Healthcare

InvestmentWorth todayGain
1 years ago$604-40%
3 years ago$754-25%
5 years ago$1,353+35%
→ See Prestige Consumer Healthcare's full return history + gain calculator

Return by year (Prestige Consumer Healthcare)

YearReturn$1,000 invested at year start
2026 (YTD)-24%$765 (-24%)
2025-21%$604 (-40%)
2024+28%$771 (-23%)
→ See Prestige Consumer Healthcare's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Prestige Consumer Healthcare

Loading news…

📋 All analyst calls on PBH

▲ Buy · 🎯$72
Price at call : $46.6 — upside +55%
Today : $51.21 — upside +41%
🎯 on PBH : 20% (5 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : May 15, 27
Oppenheimer 
May 14, 26
■ Perform neutral · not a buy
🎯 on PBH : 63% (8 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
in progress (365j)
matures : May 14, 27
Oppenheimer 
May 7, 26
▲ Outperform · 🎯$65
Price at call : $54.59 — upside +19%
Today : $51.21 — upside +27%
🎯 on PBH : 63% (8 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
in progress (365j)
matures : May 7, 27
Jefferies 
Feb 2, 26
■ Hold neutral · not a buy · 🎯$66
Price at call : $64.43 — gap to target +2%
Today : $51.21 — gap to target +29%
🎯 on PBH : 67% (3 calls matureds) · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : Feb 2, 27
▲ Buy · 🎯$88
Price at call : $60.46 — upside +46%
Today : $51.21 — upside +72%
🎯 on PBH : 20% (5 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Nov 7, 26
Jefferies 
Oct 27, 25
■ Hold neutral · not a buy · 🎯$71
Price at call : $62.41 — gap to target +14%
Today : $51.21 — gap to target +39%
🎯 on PBH : 67% (3 calls matureds) · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : Oct 27, 26
Oppenheimer 
Oct 21, 25
▲ Outperform · 🎯$72
Price at call : $63.36 — upside +14%
Today : $51.21 — upside +41%
🎯 on PBH : 63% (8 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
in progress (365j)
matures : Oct 21, 26
▲ Buy · 🎯$100
Price at call : $63.89 — upside +57%
Today : $51.21 — upside +95%
Expected +57% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 20% (5 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-17.0%
stock -17% · XLV +29%
matured Aug 8, 26
See the other 46 calls, newest to oldest
RBC Capital 
Mar 21, 25
■ Sector Perform neutral · not a buy · 🎯$97
Price at call : $85.37 — gap to target +14%
Today : $51.21 — gap to target +89%
🎯 on PBH : no call matured yet · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Mar 21, 26
Oppenheimer 
Feb 13, 25
▲ Outperform · 🎯$93
Price at call : $86 — upside +8%
Today : $51.21 — upside +82%
Expected +8% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 63% (8 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
-22.9%
stock -23% · XLV +9%
matured Feb 13, 26
▲ Buy · 🎯$100
Price at call : $87.18 — upside +15%
Today : $51.21 — upside +95%
Expected +15% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 20% (5 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-25.0%
stock -25% · XLV +7%
matured Feb 7, 26
DA Davidson 
Feb 7, 25
▲ Buy · 🎯$104
Price at call : $87.18 — upside +19%
Today : $51.21 — upside +103%
Expected +19% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
-25.0%
stock -25% · XLV +7%
matured Feb 7, 26
DA Davidson 
Nov 11, 24
▲ Buy · 🎯$95
Price at call : $81.63 — upside +16%
Today : $51.21 — upside +86%
Expected +16% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
-25.9%
stock -26% · XLV +4%
matured Nov 11, 25
DA Davidson 
Aug 28, 24
▲ Buy · 🎯$95
Price at call : $74 — upside +28%
Today : $51.21 — upside +86%
Expected +28% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
-8.1%
stock -8% · XLV -12%
matured Aug 28, 25
DA Davidson 
Aug 9, 24
▲ Buy · 🎯$93
Price at call : $65.26 — upside +43%
Today : $51.21 — upside +82%
Expected +43% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
-2.1%
stock -2% · XLV -13%
matured Aug 9, 25
▲ Buy · 🎯$81
Price at call : $65.26 — upside +24%
Today : $51.21 — upside +58%
Expected +24% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 20% (5 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-2.1%
stock -2% · XLV -13%
matured Aug 9, 25
DA Davidson 
Jun 21, 24
▲ Buy · 🎯$93
Price at call : $68.48 — upside +36%
Today : $51.21 — upside +82%
Expected +36% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
+23.2%
stock +23% · XLV -10%
matured Jun 21, 25
▲ Buy · 🎯$80
Price at call : $64.73 — upside +24%
Today : $51.21 — upside +56%
Expected +24% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on PBH : 20% (5 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
+31.3%
stock +31% · XLV -11%
matured May 21, 25
DA Davidson 
May 16, 24
■ Neutral neutral · not a buy · 🎯$65
Price at call : $64.65 — gap to target +1%
Today : $51.21 — gap to target +27%
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
in progress (365j)
matures : May 16, 25
DA Davidson 
Jun 26, 23
■ Neutral neutral · not a buy · 🎯$60
Price at call : $58.15 — gap to target +3%
Today : $51.21 — gap to target +17%
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
in progress (365j)
matures : Jun 25, 24
DA Davidson 
May 8, 23
■ Neutral neutral · not a buy · 🎯$60
Price at call : $59.5 — gap to target +1%
Today : $51.21 — gap to target +17%
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
in progress (365j)
matures : May 7, 24
RBC Capital 
Mar 17, 23
■ Sector Perform neutral · not a buy · 🎯$104
Price at call : $61.28 — gap to target +70%
Today : $51.21 — gap to target +103%
🎯 on PBH : no call matured yet · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Mar 16, 24
Oppenheimer 
Feb 17, 23
▲ Outperform · 🎯$71
Price at call : $61.14 — upside +16%
Today : $51.21 — upside +39%
Expected +16% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 63% (8 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+12.5%
stock +12% · XLV +11%
matured Feb 17, 24
Oppenheimer 
Jan 13, 23
▲ Outperform · 🎯$72
Price at call : $65.84 — upside +9%
Today : $51.21 — upside +41%
Expected +9% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 63% (8 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
-10.3%
stock -10% · XLV +4%
matured Jan 13, 24
▲ Buy · 🎯$71
Price at call : $58.44 — upside +21%
Today : $51.21 — upside +39%
Expected +21% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 20% (5 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-0.2%
stock -0% · XLV -4%
matured Nov 17, 23
Jefferies 
May 10, 22
▲ Buy · 🎯$70
Price at call : $57.57 — upside +22%
Today : $51.21 — upside +37%
Expected +22% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 67% (3 calls matureds) · 📊 on Health : 50% · +9.9% (136 calls)
+2.0%
stock +2% · XLV +5%
matured May 10, 23
Oppenheimer 
May 9, 22
▲ Outperform · 🎯$63
Price at call : $57.45 — upside +10%
Today : $51.21 — upside +23%
Expected +10% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 63% (8 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+1.7%
stock +2% · XLV +5%
matured May 9, 23
DA Davidson 
May 9, 22
■ Neutral neutral · not a buy · 🎯$60
Price at call : $57.45 — gap to target +4%
Today : $51.21 — gap to target +17%
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
in progress (365j)
matures : May 9, 23
DA Davidson 
Nov 15, 21
■ Neutral neutral · not a buy · 🎯$63
Price at call : $61.33 — gap to target +3%
Today : $51.21 — gap to target +23%
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
in progress (365j)
matures : Nov 15, 22
DA Davidson 
Aug 6, 21
■ Neutral neutral · not a buy · 🎯$61
Price at call : $58.76 — gap to target +4%
Today : $51.21 — gap to target +19%
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
in progress (365j)
matures : Aug 6, 22
DA Davidson 
May 28, 21
■ Neutral neutral · not a buy · 🎯$52
Price at call : $49.87 — gap to target +4%
Today : $51.21 — gap to target +2%
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
in progress (365j)
matures : May 28, 22
DA Davidson 
May 10, 21
■ Neutral neutral · not a buy · 🎯$49
Price at call : $46.83 — gap to target +5%
Today : $51.21 — gap to target -4%
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
in progress (365j)
matures : May 10, 22
DA Davidson 
Nov 6, 20
■ Neutral neutral · not a buy · 🎯$39
Price at call : $33.05 — gap to target +18%
Today : $51.21 — gap to target -24%
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
in progress (365j)
matures : Nov 6, 21
DA Davidson 
Aug 7, 20
■ Neutral neutral · not a buy · 🎯$45
Price at call : $39.94 — gap to target +13%
Today : $51.21 — gap to target -12%
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
in progress (365j)
matures : Aug 7, 21
Jefferies 
Mar 26, 20
▲ Buy · 🎯$43
Price at call : $35.15 — upside +22%
Today : $51.21 — upside -16%
Expected +22% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on PBH : 67% (3 calls matureds) · 📊 on Health : 50% · +9.9% (136 calls)
+28.2%
stock +28% · XLV +35%
matured Mar 26, 21
Oppenheimer 
Mar 24, 20
■ Perform neutral · not a buy
🎯 on PBH : 63% (8 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
in progress (365j)
matures : Mar 24, 21
DA Davidson 
Mar 19, 20
▲ Buy
Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
+46.4%
stock +46% · XLV +40%
matured Mar 19, 21
DA Davidson 
Nov 4, 19
■ Neutral neutral · not a buy · 🎯$32
Price at call : $38.3 — gap to target -16%
Today : $51.21 — gap to target -38%
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
in progress (365j)
matures : Nov 3, 20
Raymond James 
Jan 15, 19
■ Market Perform neutral · not a buy
🎯 on PBH : 0% (1 call matured) · 📊 on Health : 39.9% · -2.0% (218 calls)
in progress (365j)
matures : Jan 15, 20
Keybanc 
Feb 5, 18
▲ Overweight · 🎯$43
Price at call : $35.53 — upside +21%
Today : $51.21 — upside -16%
Expected +21% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 50% (2 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-20.6%
stock -21% · XLV +9%
matured Feb 5, 19
DA Davidson 
Feb 5, 18
■ Neutral neutral · not a buy
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
in progress (365j)
matures : Feb 5, 19
William Blair 
Dec 4, 17
▲ Outperform
Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 0% (1 call matured) · 📊 on Health : 32% · -10.8% (25 calls)
-22.8%
stock -23% · XLV +13%
matured Dec 4, 18
BMO Capital 
Nov 15, 17
▲ Outperform
Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 0% (1 call matured) · 📊 on Health : 43.9% · -2.1% (66 calls)
-6.6%
stock -7% · XLV +13%
matured Nov 15, 18
Jefferies 
Nov 3, 17
■ Hold neutral · not a buy · 🎯$50
Price at call : $43.07 — gap to target +16%
Today : $51.21 — gap to target -2%
🎯 on PBH : 67% (3 calls matureds) · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : Nov 3, 18
Raymond James 
May 22, 17
▲ Outperform
Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 0% (1 call matured) · 📊 on Health : 39.9% · -2.0% (218 calls)
-33.9%
stock -34% · XLV +10%
matured May 22, 18
DA Davidson 
May 9, 17
▲ Buy · 🎯$79
Price at call : $57.23 — upside +38%
Today : $51.21 — upside +54%
Expected +38% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 29% (7 calls matureds) · 📊 on Health : 41.7% · -11.4% (12 calls)
-50.2%
stock -50% · XLV +7%
matured May 9, 18
Gabelli & Co.
Nov 17, 16
▲ Buy
Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 0% (1 call matured) · 📊 unranked overall
-16.0%
stock -16% · XLV +15%
matured Nov 17, 17
Keybanc 
Mar 7, 16
▲ Overweight
Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 50% (2 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
+11.2%
stock +11% · XLV +12%
matured Mar 7, 17
Piper Sandler 
Feb 5, 16
▲ Overweight
Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on PBH : 100% (1 call matured) · 📊 on Health : 45.8% · +6.9% (249 calls)
+15.3%
stock +15% · XLV +11%
matured Feb 4, 17
Jefferies 
Jan 25, 16
▼ Underperform · 🎯$41
Price at call : $46.42 — upside -12%
Today : $51.21 — upside -20%
Expected -12% · Actual +13% · Reason (≤ −15%) : ✗ No
🎯 on PBH : 67% (3 calls matureds) · 📊 on Health : 50% · +9.9% (136 calls)
-13.2%
stock +13% · XLV +3%
matured Jan 24, 17
Oppenheimer 
Apr 28, 14
▲ Outperform · 🎯$37
Price at call : $31.91 — upside +16%
Today : $51.21 — upside -28%
Expected +16% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on PBH : 63% (8 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+30.3%
stock +30% · XLV +27%
matured Apr 28, 15
Oppenheimer 
Aug 2, 13
▲ Outperform · 🎯$39
Price at call : $35.02 — upside +11%
Today : $51.21 — upside -24%
Expected +11% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on PBH : 63% (8 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
-11.1%
stock -11% · XLV +19%
matured Aug 2, 14
Oppenheimer 
Aug 8, 12
▲ Outperform · 🎯$18
Price at call : $16.3 — upside +10%
Today : $51.21 — upside -65%
Expected +10% · Actual +101% · Reason (≥ +15%) : ✓ Yes
🎯 on PBH : 63% (8 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+101.4%
stock +101% · XLV +33%
matured Aug 8, 13
Oppenheimer 
May 18, 12
▲ Outperform · 🎯$17
Price at call : $13.85 — upside +23%
Today : $51.21 — upside -67%
Expected +23% · Actual +113% · Reason (≥ +15%) : ✓ Yes
🎯 on PBH : 63% (8 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+112.9%
stock +113% · XLV +35%
matured May 18, 13

Frequently asked questions

Should I buy Prestige Consumer Healthcare stock?

This isn't buy advice. For Prestige Consumer Healthcare, the analyst consensus is "Buy", with an average price target of $72.00 (+41% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 75% of the time (4 calls tracked on Prestige Consumer Healthcare). We show the numbers — you decide.

Is it too late to buy Prestige Consumer Healthcare? How high can it go?

The most bullish analyst target on Prestige Consumer Healthcare is $72.00 (+41% above today's price); the average is $72.00. That's the upside they see. Check how reliable those analysts have actually been on Prestige Consumer Healthcare on our site before trusting it.

Is Prestige Consumer Healthcare still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 7 analysts have a real record on Prestige Consumer Healthcare, the best hitting 75% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.

Will Prestige Consumer Healthcare stock recover (go back up)?

It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will PBH stock recover (go back up)?

What has Prestige Consumer Healthcare's past performance been?

Historical returns and a "how much if I had invested" calculator: PBH performance & returns.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)